Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mad2 who wrote (2036)	1/16/2000 12:35:00 AM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

Mad2, I have honestly been aware of pleconaril for over a year and it, like Agouron's drug, have been discussed here before. The Agouron publicity team had a blitz a short while back that was similar. It made the national news and was essentially a PR campaign to get more exposure and to get some volunteers for their studies. I posted rapidly because I am familiar with the drugs around and because I happened to notice a bunch of people posting about it here and on Yahoo. Perhaps I should have posted to John; sorry to jump on you personally. I do think that VPHM's drug has a place - probably more than Agouron's will ultimately, but it will be in treating other picornavirus infections generically (viral diarrhea and meningitis most prominently).